NANOPEP

Nanopep is a biotechnology company specializing in the development of cell-penetrating peptide (CPP) technologies for the intracellular delivery of therapeutic molecules. The company's proprietary platform utilizes non-covalent peptide-based nanoparticles to transport various cargoes, such as siRNA, mRNA, and proteins, directly into target cells while bypassing traditional endosomal entrapment. This approach addresses a major bottleneck in drug development by enabling the delivery of undruggable targets that require access to the cytoplasm or nucleus. Nanopep focuses on applications in oncology, immunology, and infectious diseases, offering both a proprietary pipeline and partnership opportunities for optimized drug formulation. Their technology is based on decades of research into amphipathic peptides that form stable, non-covalent complexes with biological cargoes.